157 related articles for article (PubMed ID: 10736587)
1. Immunogenicity of a low dose of indigenously developed recombinant hepatitis-B vaccine in neonates and infants.
Rao MN; Joshi N; Habibullah CM
Indian Pediatr; 1999 Jun; 36(6):581-3. PubMed ID: 10736587
[No Abstract] [Full Text] [Related]
2. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
[TBL] [Abstract][Full Text] [Related]
3. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
Jafarzadeh A; Zarei S; Shokri F
Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
[TBL] [Abstract][Full Text] [Related]
5. Responsiveness to intradermal recombinant hepatitis B vaccine.
CDR (Lond Engl Wkly); 1991 Oct; 1(43):198. PubMed ID: 1669886
[No Abstract] [Full Text] [Related]
6. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of indigenous recombinant hepatitis B vaccine in infants following a 0, 1, 2-month vaccination schedule.
Kumar TS; Abraham P; Raghuraman S; Cherian T
Indian Pediatr; 2000 Jan; 37(1):75-80. PubMed ID: 10745392
[No Abstract] [Full Text] [Related]
8. [The evaluation on immunogenicity of hepatitis B vaccine].
Li HM; Liang ZL; Zhang HY
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):378-81. PubMed ID: 15231155
[No Abstract] [Full Text] [Related]
9. The effect of concurrent use of hepatitis B and Bacille Calmette-Guérin vaccination on anti-hepatitis B response.
Artan R; Erol M; Velipasaoglu S; Yegin O
Saudi Med J; 2004 Dec; 25(12):1939-42. PubMed ID: 15711671
[TBL] [Abstract][Full Text] [Related]
10. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
11. Low response to hepatitis B virus vaccine in Costa Rican health-care workers.
Taylor L; García Z; Herrera G; Luftig RB; Visona KA
Hepatology; 1998 Feb; 27(2):637. PubMed ID: 9462669
[No Abstract] [Full Text] [Related]
12. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
Van Damme P; Van Herck K
Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
[TBL] [Abstract][Full Text] [Related]
13. [Immunogenicity of a recombinant vaccine against viral hepatitis B].
Russo R; Ripa F; Ditommaso S; Zotti C; Moiraghi Ruggenini A
Ann Ist Super Sanita; 1992; 28(4):563-7. PubMed ID: 1303051
[TBL] [Abstract][Full Text] [Related]
14. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
15. Clinical safety and efficacy of first indigenous recombinant hepatitis B vaccine.
Kumar A; Joshi N; Sreenivas DV; Palan S; Nagarjuna Kumar YR
J Assoc Physicians India; 1998 Jul; 46(7):620-2. PubMed ID: 12152846
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection].
Xia GL; Gong J; Wang JJ; Meng ZD; Jia ZY; Cao HL; Liu CB
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):362-5. PubMed ID: 12820927
[TBL] [Abstract][Full Text] [Related]
18. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
[TBL] [Abstract][Full Text] [Related]
20. Low response to hepatitis B vaccine in health care workers and medical students in Lisbon, Portugal.
Marinho RT; Ramalho F; Velosa J
Hepatology; 1998 Oct; 28(4):1166. PubMed ID: 9841230
[No Abstract] [Full Text] [Related]
[Next] [New Search]
